Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 22% ± 4% | |
dendritic cell | 3 studies | 23% ± 8% |
Insufficient scRNA-seq data for expression of TOP1MT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 1700.36 | 1809 / 1809 | 100% | 32.67 | 471 / 472 |
thymus | 100% | 1779.71 | 653 / 653 | 100% | 21.04 | 602 / 605 |
esophagus | 100% | 1073.19 | 1444 / 1445 | 99% | 21.52 | 181 / 183 |
prostate | 100% | 1305.31 | 245 / 245 | 99% | 15.51 | 496 / 502 |
ovary | 100% | 2359.48 | 180 / 180 | 98% | 22.49 | 423 / 430 |
liver | 100% | 1500.53 | 226 / 226 | 98% | 20.25 | 399 / 406 |
uterus | 100% | 1462.24 | 170 / 170 | 98% | 21.45 | 451 / 459 |
bladder | 100% | 1660.33 | 21 / 21 | 98% | 28.83 | 495 / 504 |
lung | 100% | 1017.78 | 576 / 578 | 98% | 20.54 | 1128 / 1155 |
intestine | 100% | 1161.96 | 965 / 966 | 97% | 32.66 | 513 / 527 |
pancreas | 100% | 989.80 | 327 / 328 | 97% | 16.39 | 173 / 178 |
breast | 100% | 1344.22 | 459 / 459 | 97% | 20.38 | 1083 / 1118 |
stomach | 100% | 925.03 | 359 / 359 | 97% | 28.12 | 277 / 286 |
kidney | 100% | 1129.15 | 89 / 89 | 90% | 10.61 | 812 / 901 |
brain | 80% | 382.51 | 2112 / 2642 | 88% | 9.55 | 619 / 705 |
adrenal gland | 100% | 1519.49 | 258 / 258 | 64% | 8.13 | 147 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 57.09 | 80 / 80 |
spleen | 100% | 1193.41 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.23 | 1 / 1 |
blood vessel | 100% | 941.80 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1278.57 | 1203 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 17.01 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 19.13 | 28 / 29 |
peripheral blood | 91% | 744.19 | 842 / 929 | 0% | 0 | 0 / 0 |
heart | 78% | 355.92 | 675 / 861 | 0% | 0 | 0 / 0 |
muscle | 74% | 340.54 | 591 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006260 | Biological process | DNA replication |
GO_0006265 | Biological process | DNA topological change |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0042645 | Cellular component | mitochondrial nucleoid |
GO_0005739 | Cellular component | mitochondrion |
GO_0003677 | Molecular function | DNA binding |
GO_0003917 | Molecular function | DNA topoisomerase type I (single strand cut, ATP-independent) activity |
Gene name | TOP1MT |
Protein name | DNA topoisomerase (EC 5.6.2.1) DNA topoisomerase I (EC 5.6.2.1) (DNA topoisomerase 1) DNA topoisomerase I mitochondrial DNA topoisomerase I, mitochondrial (TOP1mt) (EC 5.6.2.1) TOP1MT protein |
Synonyms | |
Description | FUNCTION: Releases the supercoiling and torsional tension of DNA introduced during duplication of mitochondrial DNA by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(3'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 5'-OH DNA strand. The free DNA strand then rotates around the intact phosphodiester bond on the opposing strand, thus removing DNA supercoils. Finally, in the religation step, the DNA 5'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone (By similarity). . FUNCTION: Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at the specific target site 5'-[CT]CCTTp site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(3'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 5'-OH DNA strand. The free DNA strand then undergoes passage around the unbroken strand thus removing DNA supercoils. Finally, in the religation step, the DNA 5'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone. . |
Accessions | ENST00000521193.5 [Q969P6-2] E5RFS0 E5RJ33 ENST00000522043.1 E5RGR4 ENST00000518007.5 ENST00000523417.5 E5RIC7 E5RGE7 H0YC03 ENST00000518760.5 ENST00000519148.5 [Q969P6-2] Q8TBP3 H0YBR3 E5RFE3 ENST00000518951.6 ENST00000522121.5 ENST00000520950.5 ENST00000519977.5 H0YAR3 E5RJ95 ENST00000329245.9 [Q969P6-1] ENST00000522041.5 ENST00000519139.6 E5RGR2 ENST00000523676.5 [Q969P6-2] Q969P6 ENST00000519591.5 |